HZNP

Paulson & Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,103,046	Closed	-$243M	–	18
2023 Q3	$243M	Buy	2,103,046 +1,603,046	+321%	+$185M	21.77%	1
2023 Q2	$51.4M	Sell	500,000 -500,000	-50%	-$51.4M	5.02%	7
2023 Q1	$109M	Sell	1,000,000 -500,000	-33%	-$54.6M	9.07%	5
2022 Q4	$171M	Sell	1,500,000 -4,600,000	-75%	-$523M	15.37%	2
2022 Q3	$378M	Sell	6,100,000 -99,000	-2%	-$6.13M	27.63%	1
2022 Q2	$494M	Buy	6,199,000 +585,000	+10%	+$46.7M	24.38%	1
2022 Q1	$591M	Sell	5,614,000 -386,000	-6%	-$40.6M	18.18%	1
2021 Q4	$647M	Sell	6,000,000 -169,296	-3%	-$18.2M	19.94%	2
2021 Q3	$676M	Sell	6,169,296 -1,822,144	-23%	-$200M	19.25%	2
2021 Q2	$748M	Hold	7,991,440	–	–	17.88%	2
2021 Q1	$736M	Hold	7,991,440	–	–	16.89%	2
2020 Q4	$585M	Buy	7,991,440 +1,300,001	+19%	+$95.1M	15.17%	1
2020 Q3	$520M	Sell	6,691,439 -200,000	-3%	-$15.5M	16.2%	1
2020 Q2	$383M	Sell	6,891,439 -1,279,261	-16%	-$71.1M	12.24%	2
2020 Q1	$242M	Hold	8,170,700	–	–	9.23%	3
2019 Q4	$296M	Hold	8,170,700	–	–	6.38%	5
2019 Q3	$222M	Buy	8,170,700 +1,500,000	+22%	+$40.8M	4.46%	9
2019 Q2	$160M	Hold	6,670,700	–	–	2.73%	15
2019 Q1	$176M	Sell	6,670,700 -500,000	-7%	-$13.2M	3.7%	10
2018 Q4	$140M	Hold	7,170,700	–	–	3.36%	9
2018 Q3	$140M	Sell	7,170,700 -500,000	-7%	-$9.79M	2.63%	13
2018 Q2	$127M	Hold	7,670,700	–	–	2.59%	11
2018 Q1	$109M	Sell	7,670,700 -200,000	-3%	-$2.84M	2.38%	12
2017 Q4	$115M	Buy	7,870,700 +2,291,850	+41%	+$33.5M	2.24%	14
2017 Q3	$70.7M	Buy	5,578,850 +643,350	+13%	+$8.16M	1.27%	18
2017 Q2	$58.6M	Buy	+4,935,500	New	+$58.6M	0.79%	29